XTX Topco’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

XTX Topco’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-62,938	Closed	-$139K	–	2156
2023 Q2	$139K	Buy	+62,938	New	+$131K	0.02%	1107
2023 Q1	–	Sell	-80,387	Closed	-$150K	–	1772
2022 Q4	$150K	Buy	80,387 +17,877	+29%	+$44.6K	0.03%	921
2022 Q3	$161K	Buy	62,510 +44,291	+243%	+$110K	0.04%	852
2022 Q2	$35K	Sell	18,219 -17,105	-48%	-$37.3K	0.01%	783
2022 Q1	$105K	Buy	35,324 +8,875	+34%	+$33.4K	0.05%	510
2021 Q4	$119K	Buy	26,449 +11,532	+77%	+$54.7K	0.07%	440
2021 Q3	$72K	Buy	+14,917	New	+$82.2K	0.02%	584
2021 Q2	–	Sell	-15,425	Closed	-$109K	–	1170
2021 Q1	$109K	Buy	+15,425	New	+$111K	0.05%	558

XTX Topco's PRTK Position: Q3 2023 in Review

XTX Topco sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 62,938 shares — an estimated $139K sold.

XTX Topco first reported a position in PRTK in Q1 2021 and held it in 8 quarters. The position peaked at $161K in Q3 2022. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

XTX Topco reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
XTX Topco sold 62,938 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $139K.
XTX Topco first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2021 and held it in 8 quarters.
XTX Topco's Paratek Pharmaceuticals, Inc. position peaked at $161K in Q3 2022.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on XTX Topco's 13F filing for Q3 2023, filed 13 Nov 2023.